The Clinician Looks at Fatty Liver

  • Sheila Sherlock
Part of the Topics in Gastroenterology book series (TGEN)

Abstract

Fatty liver is now being diagnosed more often than in the past. The diagnosis may follow a clinically suspicious condition, e.g., unexplained hepatomegaly, but increasingly it accompanies the use of special techniques such as computerized tomography (CT), ultrasound, and liver biopsy.1 In some instances the cause of fatty liver is obvious, such as alcoholism or obesity. In other instances the fatty change is a small part of another condition such as non-A, non-B hepatitis or Wilson’s disease. It may be an integral part of a widespread metabolic abnormality such as Reye’s syndrome. Finally, there remains a large group for whom the cause of the fatty liver is never determined.

Keywords

Liver Biopsy Fatty Liver Hepatic Steatosis Fatty Infiltration Alcoholic Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sherlock S. Diseases of the Liver and Biliary System, 7th ed. Oxford: Blackwell Scientific, 1985; pp. 381–385.Google Scholar
  2. 2.
    Hoyumpa AM, Green HL, Dunn GD, Schenker S. Fatty liver: Biochemical and clinical considerations. Dig Dis Sci 1975;20:1142–1170.CrossRefGoogle Scholar
  3. 3.
    Saverymuttu SH, Joseph AEA, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. MJ 1986;292:13–15.CrossRefGoogle Scholar
  4. 4.
    Scatarige JC, Scott WW, Donovan PJ et al. Fatty infiltration of the liver: Ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984;3:9–14.PubMedGoogle Scholar
  5. 5.
    McKee CM, Weir PE, Murnaghan GA, Callender ME. Acute fatty liver of pregnancy and diagnosis by computed tomography. Br Med J 1986;292:291–292.CrossRefGoogle Scholar
  6. 6.
    Bydder GM, Kreel L, Chapman RWG, Harry D, Sherlock S. Accuracy of computed tomography in diagnosis of fatty liver. Br Med J 1980;281:1042–1044.PubMedCrossRefGoogle Scholar
  7. 7.
    Heiken JP, Lee JKT, Dixon WT. Fatty infiltration of the liver: Evaluation by proton spectroscopic imaging. Radiology 1985;157:707–710.PubMedGoogle Scholar
  8. 8.
    Scheuer PJ. Liver Biopsy Interpretation, 3rd ed. London: Bailliere-Tindall, 1980.Google Scholar
  9. 9.
    Baptista A, Bianchi L, DeGroote J et al. Alcoholic liver disease: Morphological manifestations. Review by an international group. Lancet 1981;1:707–711.Google Scholar
  10. 10.
    Uchida T, Kao H, Quispe-Sjogren M et al. Alcoholic foamy degeneration: A pattern of acute alcoholic injury of the liver. Gastroenterology 1983;84:683–692.PubMedGoogle Scholar
  11. 11.
    Christoffersen P, Braendstrup O, Juhl E et al. Lipogranulomas in human liver biopsies with fatty change. Acta Pathol Microbiol Scand Sec A 1971;19:150–158.Google Scholar
  12. 12.
    Sorensen TIA, Orholm M, Bentsen KD et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of the development of cirrhosis. Lancet 1984;2:241–243.PubMedCrossRefGoogle Scholar
  13. 13.
    Randall BR. Fatty liver and sudden death: A review. Hum Pathol 1980;11:147–153.PubMedCrossRefGoogle Scholar
  14. 14.
    Braillon A, Capron JP, Herve MA, Degott C, Quenu MC. Liver in obesity. Gut 1985;26:133–139.PubMedCrossRefGoogle Scholar
  15. 15.
    Nasrulla SM, Wills CE Jr, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci 1981;26:325–327.CrossRefGoogle Scholar
  16. 16.
    Adler M, Schaffner F. Fatty liver, hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811–816.PubMedCrossRefGoogle Scholar
  17. 17.
    Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: A cause of chronic liver dysfunction. Am J Gastroenterol 1983;78:374–377.PubMedGoogle Scholar
  18. 18.
    Mavrelis PG, Ammon HV, Gleysteen JJ et al. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 1983;3:226–231.PubMedCrossRefGoogle Scholar
  19. 19.
    Sherlock S, Beam AG, Billing B. The effect of insulin on the liver in normal and diabetic man. In Trans 10th Conf Liver Injury. New York: Josiah Macy Jr. Foundation.Google Scholar
  20. 20.
    Bray GA. Complications of obesity. Ann Intern Med 1985;103:1052–1062.PubMedGoogle Scholar
  21. 21.
    Cherrington AD, Steiner KE. The effects of insulin on carbohydrate metabolism in vivo. Clin Endocrinol Metab 1982;11:307–328.PubMedCrossRefGoogle Scholar
  22. 22.
    Robbers H, Strohfeldt P, Kruger CH. Differential diagnosis between diabetic and alcoholic fatty liver: A study of 171 diabetics and 100 chronic alcoholics. German Med Monthly 1968;13:124–125.Google Scholar
  23. 23.
    Itoh S, Tsukada Y, Motomura Y, Ichinoe A. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol 1979;26:90–97.Google Scholar
  24. 24.
    Falchuk KR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 1980;78:535–541.PubMedGoogle Scholar
  25. 25.
    Batman PA, Scheuer PJ. Diabetic hepatitis preceding the onset of glucose intolerance. Histopathology 1985;9:237–243.PubMedCrossRefGoogle Scholar
  26. 26.
    McGill DB, Hympherys SR, Baggenstoss AH, Dickson ER. Cirrhosis and death after jejunoileal shunt. Gastroenterology 1972;63:872–877.PubMedGoogle Scholar
  27. 27.
    Haines NW, Baker AL, Boyer JL et al. Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: A prospective study. Hepatology 1981;1:161–167.PubMedCrossRefGoogle Scholar
  28. 28.
    Wolfe RR, O’Donnell TF, Stone MD et al. Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition. Metabolism 1980;29:892–900.PubMedCrossRefGoogle Scholar
  29. 29.
    Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery 1980;88:93–100.PubMedGoogle Scholar
  30. 30.
    Bengoa JM, Hanauer SB, Sitrin MD, Baker AL, Rosenberg IH. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease. Hepatology 1985;5:79–84.PubMedCrossRefGoogle Scholar
  31. 31.
    Truswell AS, Hansen JDL, Watson CE, Wannenburg P. Relation of serum lipids and lipoproteins to fatty liver in kwashiorkor 1,2. Am J Clin Nutr 1969;22:568–576.PubMedGoogle Scholar
  32. 32.
    Cook GC, Hutt MSR. The liver after kwashiorkor. Br Med J 1967;3:454–457.PubMedCrossRefGoogle Scholar
  33. 33.
    Avigan MI, Ishak KG, Gregg RE, Hoofnagle JH. Morphologic features of the liver in abeta-lipoproteinemia. Hepatology 1984;4:1223–1226.PubMedCrossRefGoogle Scholar
  34. 34.
    Beaugrant M, Poupon R, Levy VG et al. Lesions hepatiques dues au maleate de perhexiline. Etude clinique, biologique, histopathologique, ultrastructurale et biochemique de 7 cas. Gastroenterol Clin Biol 1978;2:579–588.Google Scholar
  35. 35.
    Poucell S, Ireton J, Valencia-Mayoral P et al. Aminodarone-associated phospholipidosis and fibrosis of the liver: Light, immunohistochemical and electron microscopic studies. Gastroenterology 1984;86:926–936.PubMedGoogle Scholar
  36. 36.
    Morgan MY, Reshef R, Shah RR, Oates NS, Smith RL, Sherlock S. Impaired oxidation of debrisoquine in patients with perhexiline liver injury. Gut 1984;25:1057-.PubMedCrossRefGoogle Scholar
  37. 37.
    Simon JB, Manley PN, Brien JF, Armstrong PW. Amiodarone hepatoxicity simulating alcoholic liver disease. N Engl J Med 1984;311:167–172.PubMedCrossRefGoogle Scholar
  38. 38.
    Seki K, Minami Y, Nishikawa M et al. Non-alcoholic steatohepatitis induced by massive doses of synthetic estrogen. Gastroenterol Japan 1983;18:197–203.Google Scholar
  39. 39.
    Gyorgy P, Goldblatt H. Hepatic injury on nutritional basis in rats. J Exp Med 1939;70:185–192.PubMedCrossRefGoogle Scholar
  40. 40.
    Hartroft WS. Intracellular (“pseudo-alcoholic”) lyalin in experimental dietary cirrhosis of rats and mice. Am J Pathol 1958;34:603.Google Scholar
  41. 41.
    Dordal E, Glagov S, Kirsner JB. Hepatic lesions in chronic inflammatory bowel disease. 1. Clinical correlations with liver biopsy diagnosis in 103 patients. Gastroenterology 1967;52:239–253.PubMedGoogle Scholar
  42. 42.
    Eade MN. Liver disease in ulcerative colitis. 1. Analysis of operative liver biopsy in 138 consecutive patients having colectomy. Ann Intern Med 1970;72:475–487.PubMedGoogle Scholar
  43. 43.
    Neale G, Antcliff AC, Welbourn RB, Mollin DL, Booth CC. Protein malnutrition after partial gastrectomy. Q J Med 1967;36:469–94.PubMedGoogle Scholar
  44. 44.
    Kimura H, Kako M, Yo K, Oda T. Alcoholic hyalins (Mallory bodies) in a case of Weber-Christian disease: Electron microscopic observations of liver involvement. Gastroenterology 1980;78:807–812.PubMedGoogle Scholar
  45. 45.
    Kryger P, Christoffersen P. Light microscopic morphology of acute hepatitis non-A, non-B: A comparison with hepatitis type A and B. Liver 1982;2:200.PubMedGoogle Scholar
  46. 46.
    Alvarez SJ. Chronic hepatitis with fatty changes. Hepatology 1983;3:1058 (abstract).Google Scholar
  47. 47.
    Bruguera M, Zambon D, Ros E, Sanchhez Tapias JM, Rodes J. Chronic hepatitis: A possible etiology of fatty liver. Liver 1985;5:111–116.PubMedGoogle Scholar
  48. 48.
    Altman AR, Gottfried EB, Paronetto F, Lieber CS. Idiopathic familial cirrhosis and steatosis in adults. Gastroenterology 1979;77:1211–1216.PubMedGoogle Scholar
  49. 49.
    Sherlock S. Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut 1983;24:265–269.PubMedCrossRefGoogle Scholar
  50. 50.
    Burroughs AK, Seong NH, Dojcinov DM, Scheuer PJ, Sherlock SVP. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 1982;481–497.Google Scholar
  51. 51.
    Pockros PJ, Peters RL, Reynolds TB. Idiopathic fatty liver of pregnancy: Findings in ten cases. Medicine (Baltimore) 1984;63:1–11.PubMedCrossRefGoogle Scholar
  52. 52.
    Kaplan MM. Current concepts. Acute fatty liver of pregnancy. N Engl J Med 1985;313:367–370.PubMedCrossRefGoogle Scholar
  53. 53.
    Weber FL Jr, Snodgrass PJ, Powell DE, Rao P, Huffman SL, Brady PG. Abnormalities of hepatic mitochondrial urea-cycle enzyme activities and hepatic ultrastructure in acute fatty liver of pregnancy. J Lab Clin Med 1979;94:27–41.PubMedGoogle Scholar
  54. 54.
    Partin JC. Reye’s syndrome (encephalopathy and fatty liver): Diagnosis and treatment. Gastroenterology 1975;69:511–518.PubMedGoogle Scholar
  55. 55.
    de Vivo DC. How common is Reye’s syndrome? N Engl J Med 1983;309:179–181.CrossRefGoogle Scholar
  56. 56.
    Halpin TJ, Holtzhauer FJ, Campbell RJ et al. Reye’s syndrome and medication use. J Am Med Assoc 1982;248:687–691.CrossRefGoogle Scholar
  57. 57.
    Pande SV, Blanchaer MC. Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl coenzyme A esters. J Biol Chem 1971;246:402–411.PubMedGoogle Scholar
  58. 58.
    Kang ES, Capaci MT, Korones DN, Tekade N. Liver coenzyme A ester content: comparison between Reye’s syndrome and control subjects. Clin Sci 1982;63:455–460.PubMedGoogle Scholar
  59. 59.
    Kunelis CT, Peters RL, Edmondson HA. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965;38:359–377.PubMedCrossRefGoogle Scholar
  60. 60.
    Schiffer MA. Fatty liver associated with administration of tetracycline in pregnant and nonpregnant women. Am J Obstet Gynecol 1966;96:326–332.PubMedGoogle Scholar
  61. 61.
    Zimmerman HJ, Ishak KG. Valproate-induced hepatic injury: Analysis of 23 fatal cases. Hepatology 1982;2:591–597.PubMedCrossRefGoogle Scholar
  62. 62.
    Zanfrani ES, Berthelot P. Sodium valproate in the induction of unusual heaptotoxicity. Hepatology 1982;2:648–649.CrossRefGoogle Scholar
  63. 63.
    Bonnell HJ, Beckwith JB. Fatty liver in sudden childhood death. Implications for Reye’s syndrome? Am J Dis Child 1986;140:30–33.PubMedGoogle Scholar
  64. 64.
    Hjelm M, de Silva LYK, Seakins JWT, Oberholzer VG. Evidence of inherited urea cycle defect in a case of fatal valproate toxicity. Br Med J 1986;292:23–24.CrossRefGoogle Scholar
  65. 65.
    Morgan MY, Sherlock S, Scheuer PJ. Acute cholestasis, hepatic failure and fatty liver in the alcoholic. Scand J Gastroenterol 1978;13:299–303.PubMedCrossRefGoogle Scholar
  66. 66.
    Uchida T, Kao H, Quispe-Sjogren M et al. Alcoholic foamy degeneration: A pattern of acute alcoholic injury of the liver. Gastroenterology 1983;84:683–692.PubMedGoogle Scholar
  67. 67.
    Histologic studies of severe delta agent infection in Venezuelan indians. Hepatology 1983;3:906–912.Google Scholar
  68. 68.
    Hadler SC, De Monzon M, Ponzetto A et al. Delta virus infection and severe hepatitis: An epidemic in the Yucpa indians of Venezuela. Ann Intern Med 1984;100:339–344.PubMedGoogle Scholar
  69. 69.
    Bensebath G. Hepatite de Labrea (febre negra de Labrea) e outras hepatites fulminantes en Sena Madureira, Acre e Boca do. Inst Med Trop Sao Paulo 1983;25:182–194.Google Scholar
  70. 70.
    Buitrago B, Popper H, Hadler SC et al. Specific histologic features of Santa Marta hepatitis: a severe form of hepatitis delta virus infection in northern South America. Hepatology 1986; in press.Google Scholar
  71. 71.
    Ciain JE, Stephens DH, Charboneau JW. Ultrasonography and computed tomography in focal fatty liver. Gastroenterology 1984;87:948–952.Google Scholar
  72. 72.
    Brawer MK, Austin GE, Lewin KJ. Focal fatty change of the liver, a hitherto poorly recognized entity. Gastroenterology 1980;78:247–252.PubMedGoogle Scholar
  73. 73.
    Mulhern CB Jr, Arger PH, Coleman BG, Stein GN. Non-uniform attenuation in computed tomography study of the cirrhotic liver. Radiology 1979;132:399–402.PubMedGoogle Scholar
  74. 74.
    Yates CK, Streight RA. Focal fatty infiltration of the liver simulating metastatic disease. Radiology 1986;159:83–84.PubMedGoogle Scholar
  75. 75.
    Alpern MB, Lawson TL, Foley WD et al. Focal hepatic masses and hepatic infiltration detected by enhanced dynamic CT. Radiology 1986;158:45–49.PubMedGoogle Scholar
  76. 76.
    Swobodnik W, Wechsler JG, Manne W, Ditschuneit H. Multiple regular circumscript fatty infiltrations of the liver. J Clin Ultrasound 1985;13:577–580.PubMedCrossRefGoogle Scholar
  77. 77.
    Flournoy JG, Potter JL, Sullivan BM, Gerza BM, Ramzy I. CT appearance of multifocal hepatic steatosis. J Comput Assist Tomogr 1984;8:1192–1194.PubMedCrossRefGoogle Scholar
  78. 78.
    Patel S, Sandler CM, Rauschkolb EN, McConnell BJ. 131 Xe uptake in focal hepatic fat accumulation: CT correlation. Am J Roentgenol 1982;138:1192–1194.Google Scholar
  79. 79.
    Gale ME, Gerzof SG, Robbins AH. Portal architecture: A differential guide of fatty infiltration of the liver on computed tomography. Gastrointest Radiol 1983;8:231–236.PubMedCrossRefGoogle Scholar
  80. 80.
    Marchai G, Tshibwabwa-Tumba E, Verbeken E et al. “Skip-areas” in hepatic steatosis: A sonographic-angiographic study. Gastrointest Radiol 1986;11:151–157.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Sheila Sherlock
    • 1
  1. 1.Department of SurgeryRoyal Free Hospital School of MedicineLondonEngland

Personalised recommendations